J&J/Alza Spins Off Macroflux Unit Focused On Transdermal Drug Delivery
This article was originally published in The Pink Sheet Daily
Executive Summary
Macroflux technology provides a transdermal delivery system for therapeutic proteins, peptides and vaccines.
You may also be interested in...
Lilly Licenses Hormone Patch For Osteoporosis
Lilly Licenses Hormone Patch For Osteoporosis
Lilly Licenses Hormone Patch For Osteoporosis
Lilly Licenses Hormone Patch For Osteoporosis
J&J/Alza’s Ionsys To Launch In 2007
The fentanyl treatment’s availability waits on completion of a risk management plan despite FDA approval.